ES2131463B1 - Derivados de ciclopropilglicina con propiedades farmaceuticas. - Google Patents

Derivados de ciclopropilglicina con propiedades farmaceuticas.

Info

Publication number
ES2131463B1
ES2131463B1 ES009700736A ES9700736A ES2131463B1 ES 2131463 B1 ES2131463 B1 ES 2131463B1 ES 009700736 A ES009700736 A ES 009700736A ES 9700736 A ES9700736 A ES 9700736A ES 2131463 B1 ES2131463 B1 ES 2131463B1
Authority
ES
Spain
Prior art keywords
optionally substituted
alkyl
cycloalkyl
substituted phenyl
cyclopropylglycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009700736A
Other languages
English (en)
Other versions
ES2131463A1 (es
Inventor
Tercero Concepcion Pedregal
Cano Ivan Collado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly SA
Original Assignee
Lilly SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly SA filed Critical Lilly SA
Priority to ES009700736A priority Critical patent/ES2131463B1/es
Priority to US09/054,874 priority patent/US6172058B1/en
Priority to AT98302693T priority patent/ATE251119T1/de
Priority to ES98302693T priority patent/ES2209063T3/es
Priority to CA002234025A priority patent/CA2234025A1/en
Priority to EP98302693A priority patent/EP0870760B1/en
Priority to DE69818538T priority patent/DE69818538T2/de
Priority to JP10094423A priority patent/JPH10287633A/ja
Publication of ES2131463A1 publication Critical patent/ES2131463A1/es
Application granted granted Critical
Publication of ES2131463B1 publication Critical patent/ES2131463B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Derivados de ciclopropilglicina con propiedades farmacéuticas. Un compuesto farmacéutico de la fórmula (I), en la que R{sup,1 es alquilo C{sub,1-10 , alquenilo C{sub,2-10 , alquinilo C{sub,2-10 , cicloalquilo C{sub,3-10 , cicloalquilo C{sub,3-10 -alquiloC{sub,1-10 , cicloalquilo C{sub,3-10 -alquenilo C{sub,2-10 , cicloalquilo C{sub,3-10 -alquinilo C{sub,2-10 , fenilo opcionalmente sustituido-alquilo C{sub,1-10 , fenilo opcionalmente sustituido-alquenilo C{sub,2-10 , fenilo opcionalmente sustituido-alquinilo C{sub,2-10 , naftilo opcionalmente sustituido, naftilo opcionalmente sustituido-alquilo C{sub,1-10 , alcoxi C{sub,1-10 -alquilo C{sub,1-10 , cicloalcoxi C{sub,3-10 -alquilo C{sub,1-10 , radical heterocíclico opcionalmente sustituido, radical heterocíclico opcionalmente sustituido-alquilo C{sub,1-10 , fenilo opcionalmente sustituido condensado con cicloalquilo C{sub,5-10 , grupo tricíclico opcionalmente sustituido, grupo tricíclico opcionalmente sustituido-alquilo C{sub,1-10 o [fenilo opcionalmente sustituido(CH{sub,2 ){sub,n ]{sub,2 -alquilo C{sub,1-10 , donde n es 0 ó 1 a 4, y R{sup,2 es hidrógeno o uno de los valores de R{sup,1 ; o una sal o éster del mismo.
ES009700736A 1997-04-08 1997-04-08 Derivados de ciclopropilglicina con propiedades farmaceuticas. Expired - Fee Related ES2131463B1 (es)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ES009700736A ES2131463B1 (es) 1997-04-08 1997-04-08 Derivados de ciclopropilglicina con propiedades farmaceuticas.
US09/054,874 US6172058B1 (en) 1997-04-08 1998-04-03 Compounds with pharmaceutical properties
ES98302693T ES2209063T3 (es) 1997-04-08 1998-04-06 Derivados de la ciclopropil glicina con propiedades farmaceuticas.
CA002234025A CA2234025A1 (en) 1997-04-08 1998-04-06 Novel compounds with pharmaceutical properties
AT98302693T ATE251119T1 (de) 1997-04-08 1998-04-06 Cyclopropyl-derivate mit pharmazeutischen eigenschaften
EP98302693A EP0870760B1 (en) 1997-04-08 1998-04-06 Cyclopropyl glycine derivatives with pharmaceutical properties
DE69818538T DE69818538T2 (de) 1997-04-08 1998-04-06 Cyclopropyl-Derivate mit pharmazeutischen Eigenschaften
JP10094423A JPH10287633A (ja) 1997-04-08 1998-04-07 中枢神経系疾患治療用のシクロプロピルグリシン化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009700736A ES2131463B1 (es) 1997-04-08 1997-04-08 Derivados de ciclopropilglicina con propiedades farmaceuticas.

Publications (2)

Publication Number Publication Date
ES2131463A1 ES2131463A1 (es) 1999-07-16
ES2131463B1 true ES2131463B1 (es) 2000-03-01

Family

ID=8298874

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009700736A Expired - Fee Related ES2131463B1 (es) 1997-04-08 1997-04-08 Derivados de ciclopropilglicina con propiedades farmaceuticas.
ES98302693T Expired - Lifetime ES2209063T3 (es) 1997-04-08 1998-04-06 Derivados de la ciclopropil glicina con propiedades farmaceuticas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES98302693T Expired - Lifetime ES2209063T3 (es) 1997-04-08 1998-04-06 Derivados de la ciclopropil glicina con propiedades farmaceuticas.

Country Status (7)

Country Link
US (1) US6172058B1 (es)
EP (1) EP0870760B1 (es)
JP (1) JPH10287633A (es)
AT (1) ATE251119T1 (es)
CA (1) CA2234025A1 (es)
DE (1) DE69818538T2 (es)
ES (2) ES2131463B1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1189874B1 (en) 1999-06-03 2005-01-26 Lilly, S.A. Excitatory amino acid receptor modulators
AU5073600A (en) 1999-06-03 2000-12-28 Lilly, S.A. Excitatory amino acid receptor modulators
US7125871B2 (en) * 2000-05-31 2006-10-24 Eli Lilly And Company Excitatory amino acid receptor modulators
US7081481B2 (en) * 2000-05-31 2006-07-25 Eli Lilly And Company Excitatory amino acid receptor modulators
AU6455501A (en) * 2000-05-31 2001-12-11 Lilly Co Eli Excitatory amino acid receptor modulators
AU2001264554A1 (en) * 2000-05-31 2001-12-11 Eli Lilly And Company Excitatory amino acid receptor modulators
SI1448205T1 (sl) * 2001-10-05 2011-07-29 Zalicus Inc Kombinacije za zdravljenje imunoinflamatornih motenj
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
TWI417095B (zh) * 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
JP5433579B2 (ja) * 2007-09-14 2014-03-05 ジャンセン ファーマシューティカルズ， インコーポレイテッド． １，３−二置換−４−フェニル−１ｈ−ピリジン−２−オン
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
TWI445532B (zh) 2007-09-14 2014-07-21 Janssen Pharmaceuticals Inc １’，３’－二取代－４－苯基－３，４，５，６－四氫－２ｈ，１’ｈ－〔１，４’〕聯吡啶基－２’－酮化物
ES2637794T3 (es) * 2007-11-14 2017-10-17 Janssen Pharmaceuticals, Inc. Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
CA2735764C (en) 2008-09-02 2016-06-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
ES2466341T3 (es) 2008-10-16 2014-06-10 Janssen Pharmaceuticals, Inc. Derivados de indol y benzomorfolina como moduladores de receptores de glutamato metabotrópicos
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SG176018A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MX2011011964A (es) 2009-05-12 2012-02-23 Janssen Pharmaceuticals Inc Derivados de 1,2,3-triazolo[4,3-a]piridina y su uso para el tratamiento o prevencion de trastornos neurologicos y psiquiatricos.
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
PL2649069T3 (pl) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
JP5852666B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
US9187439B2 (en) 2011-09-21 2015-11-17 Inception Orion, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
US9499586B2 (en) * 2012-10-16 2016-11-22 Hong Kong Baptist University Anticancer and anti-obesity cyclic peptide agents
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
DK3096790T3 (da) 2014-01-21 2019-10-07 Janssen Pharmaceutica Nv Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse
UA127921C2 (uk) 2014-01-21 2024-02-14 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування
AR108326A1 (es) * 2016-04-27 2018-08-08 Samumed Llc Isoquinolin-3-il carboxamidas y preparación y uso de las mismas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959463A (en) 1985-10-15 1990-09-25 Genentech, Inc. Intermediates
CA1305177C (en) * 1987-06-30 1992-07-14 Yasufumi Ohfune Carboxycyclopropylglycine and process for producing the same
JP3481975B2 (ja) 1992-09-08 2003-12-22 サントリー株式会社 （２ｓ，１’ｓ，２’ｒ）−２−（２−カルボキシ−３−置換オキシメチルシクロプロピル）グリシン及びその製造法
GB9325368D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
ES2139928T3 (es) 1994-09-08 2000-02-16 Lilly Co Eli Antagonistas de receptores de aminoacidos de excitacion.
JPH08301825A (ja) * 1995-03-07 1996-11-19 Suntory Ltd ３’−置換−（２−カルボキシシクロプロピル）グリシン
IT1276153B1 (it) * 1995-11-17 1997-10-27 Roberto Pellicciari Derivati di glicina ad attivita' antagonista dei recettori metabotropi del glutammato
EP0913389A4 (en) 1996-06-28 2000-02-02 Nippon Chemiphar Co CYCLOPROPYLGLYCINE DERIVATIVES AND AGONISTS OF THE L-GLUTAMATE RECEPTOR TYPE OF METABOLITE REGULATION

Also Published As

Publication number Publication date
CA2234025A1 (en) 1998-10-08
ES2131463A1 (es) 1999-07-16
ATE251119T1 (de) 2003-10-15
EP0870760A1 (en) 1998-10-14
DE69818538D1 (de) 2003-11-06
US6172058B1 (en) 2001-01-09
DE69818538T2 (de) 2004-08-05
EP0870760B1 (en) 2003-10-01
ES2209063T3 (es) 2004-06-16
JPH10287633A (ja) 1998-10-27

Similar Documents

Publication Publication Date Title
ES2131463B1 (es) Derivados de ciclopropilglicina con propiedades farmaceuticas.
ES2101960T3 (es) Lactamas benzo-condensadas.
ITMI921203A1 (it) Derivati di s-triazina come agenti fotostabilizzanti
NO931917L (no) Farmas!ytiske forbindelser
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ATE214698T1 (de) Neue carbamazepin hapten analoge
EA199700160A1 (ru) Производные индола в качестве антагонистов eaa
KR960007592A (ko) 신규한 피롤로카바졸
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
IS1726B (is) Hliðstæðar aðferðir til framleiðslu á andróstenónafleiðu og milliefni notuð í aðferðunum
DE69416191D1 (de) Spiropyran-Derivate mit photochromischen Eigenschaften
DE69431824D1 (de) Verfahren zur Herstellung von Schwefelhaltigen Imidazolderivaten und erhaltene Zwischenprodukte
NO904187D0 (no) Benzanilider.
DE68902490T2 (de) Pharmazeutische zusammensetzung.
DE68904203T4 (de) Cysteinderivate.
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
DK0468445T3 (da) Fremgangsmåde til fremstilling af 6-(substitueret aminopropionyl)-derivater af forskolin
PT90815A (pt) Processo de preparacao de derivados da fenotiazina
EP0826663A3 (en) Alkynylamino acid derivatives and their use as pharmaceutical compounds

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990716

Kind code of ref document: A1

Effective date: 19990716

FD1A Patent lapsed

Effective date: 20050409